{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:35:24Z","timestamp":1790573724034,"version":"4.1.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Ewing sarcoma (ES) represents the second most common malignant bone tumor in children and young adults. ES is not a frequent finding in sites different from the skeletal. Common sites of appearance of ES are lower extremities, the pelvis, paravertebral spaces and head and neck. Primary extraskeletal ES located in the anterior mediastinum are very rare. These neoplasms should be discussed in specialized contests with a high volume of patients treated. Here, we present an uncommon mediastinal mass challenging in its characterization and management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>A thirty-year-old woman performed a thoracic CT scan for dyspnea and persistent cough. Imaging showed a solid mass of 14 x 11 cm involving the left thorax with mediastinal deviation to the right side. Patient underwent an en bloc resection of the mass. Initial histological examination was suggestive for B3 thymoma\/thymic carcinoma. Patient was then referred to our rare tumor reference center where a histological review excluded the diagnosis of thymic\/thymoma neoplasms meanwhile a third revision assessed a diagnosis of ES. Patient refused adjuvant chemotherapy due to her desire of maternity and radiation therapy was not indicated because surgery was performed too many months earlier. A close follow-up was considered. After a few months the patient relapsed and first line chemotherapy was proposed. She reached a complete response at the first evaluation maintained also at the end of the protocol. In order to consolidate the obtained response, high dose chemotherapy followed by autologous stem cell transplantation (HDCT\/ASCT) was suggested and the patient agreed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This case underlined that, potentially, ES can arise from any soft tissue site in the body, even in rare sites such as mediastinum. The evaluation of expert centers was critical to establish a correct diagnosis and therapeutic approach in this complex case. Taking into account the time lasting from the diagnosis and the aggressiveness of this kind of neoplasm, frequently relapsing, the patient after a multidisciplinary discussion was a candidate for a multimodal treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1074378","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T11:25:37Z","timestamp":1674732337000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Extraskeletal Ewing\u2019s sarcoma of the mediastinum: Case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Aldo","family":"Caltavituro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Buonaiuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Morra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Pietroluongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Peddio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Picozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ottaviano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovannella","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO\u2013 EURACAN clinical practice guidelines for diagnosis, treatment and follow- up\u2020\u2020FootnotesApproved by the ESMO guidelines committee and EURACAN: December 2017","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27555","article-title":"Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions","volume":"118","author":"Mastrangelo","year":"2012","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(04)01385-3","article-title":"Uncommon primary mediastinal tumours","volume":"5","author":"Macchiarini","year":"2004","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(98)70333-2","article-title":"Primary sarcomas of the mediastinum: results of therapy","volume":"115","author":"Burt","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The 2021 WHO classification of tumors of the thymus and mediastinum: What is new in thymic epithelial, germ cell, and mesenchymal tumors","volume":"17","author":"Marx","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2020.10.131","article-title":"The eighth edition TNM stage classification for thymic tumors: What do I need to know","volume":"161","author":"Ahmad","year":"2021","journal-title":"J Thorac Cardiovasc Surg Elsevier"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.1995","article-title":"Bone sarcomas: ESMO-EURACAN- GENTURIS-ERNPaedCan clinical practice guidelines for diagnosis, treatment and follow- up on behalf of the ESMO guidelines committee, EURACAN, GENTURIS & ERNPaedC;Published in 2021","volume":"32","author":"Strauss","year":"2021","journal-title":"Ann Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200108000-00011","article-title":"Expression of fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics","volume":"25","author":"Folpe","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12079-017-0445-z","article-title":"CD99 at the crossroads of physiology and pathology","volume":"12","author":"Pasello","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130237","article-title":"Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets","volume":"7","author":"Lessnick","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2006.12.009","article-title":"The biology of Ewing sarcoma","volume":"254","author":"Riggi","year":"2007","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4103\/ijmpo.ijmpo_24_17","article-title":"Metastatic ewing\u2019s sarcoma: Revisiting the \u201cEvidence on the fence\u201d","volume":"38","author":"Khanna","year":"2017","journal-title":"Indian J Med Paediatr Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2640674","DOI":"10.1155\/2018\/2640674","article-title":"Role of high-dose chemotherapy and autologous hematopoietic cell transplantation for children and young adults with relapsed ewing\u2019s sarcoma: A systematic review","author":"Tenneti","year":"2018","journal-title":"Sarcoma"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.17_suppl.LBA2","article-title":"Phase III assessment of topotecan and cyclophosphamide and high-dose ifosfamide in rEECur: An international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES)","volume":"40","author":"McCabe","year":"2022","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3329-2-12","article-title":"Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced ewing\u2019s and other small round cell sarcomas","volume":"2","author":"Whelan","year":"2012","journal-title":"Clin Sarcoma Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1074378\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T11:25:40Z","timestamp":1674732340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1074378\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":16,"alternative-id":["10.3389\/fonc.2023.1074378"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1074378","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"article-number":"1074378"}}